PT-141
-
Post Date:
Dec 23,2015
-
Expiry Date:
Jun 20,2016
-
Detailed Description:
Cas No. :PT-141
Quantity: 1000000Kilograms
Specs:99%
Price:1 USD Kilograms
Payment Method: west union,T/T,money gram
PT-141
Basic Info.
Model NO.:PT-141
Export Markets:Global
Additional Info.
Packing:According to Your Demand
Standard:USP 99%
Origin:China
Production Capacity:1000kg/Month
Product Description
PT-141 10mg (Bremelanotide 10mg)
PT-141 or Bremelanotide is the generic term for a research peptide being studied for its possible use in helping to improve sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder). PT-141 was developed from the tanning peptide Melanotan 2, which is a synthetically produced variant of a peptide hormone naturally produced in the body that stimulates melanogenesis that is known as alpha-Melanocyte stimulating hormone. MSH, activates certain melanocortin receptors in the process of exerting its effects. Indeed, MSH also exerts potent influence over lipid metabolism, appetite, and sexual libido. Resultantly, PT-141 has been shown in studies to exhibit libido-enhancing effects by activating the melanocortin receptors MC1R and MC4R, but not skin tanning. Melanotan 1 and Melanotan 2 have been researched for their use in protecting against the harmful effects of ultraviolet radiation from sunlight due to their melanogenesis-stimulating properties
-
CAS Registry Number:
PT-141
-
Synonyms:
BREMELANOTIDE;Brmelanotice;Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys)-OH;(3S,6S,9R,12S,23S)-15-[(N-acetyl-L-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxylic acid;Brmelanotide;PT141;Bromelanotide;Bremelanotide (PT-141);
-
Molecular Formula:
C50H68N14O10
-
Molecular Weight:
1025.1627
-
Molecular Structure:
-
Company:
Hubei Yuancheng Saichuang Technology Co., ltd.
[ China ]
-
Contact:
merry
-
Tel:
86-027-50756155
-
Fax:
86-027-68886696
-
Email:
mxy02@ycphar.com
Inquiry